The Industry and Information Technology Department of Hebei Province has released the list of the first batch of innovative small and medium-sized enterprises (SMEs) for 2024. Laviana Pharma (Cangzhou) Co., Ltd. has been recognized as an innovative SME due to its strong research and development capabilities in the pharmaceutical industry and its provision of manufacturing services (CDMO).

Innovative small and medium-sized enterprises (SMEs) are companies that are at the forefront of innovation, with powerful technological strength, strong research and development capabilities, and significant growth potential. They play a crucial role in fostering a high-quality business environment. Laviana Pharma's recognition as an "Innovative SME" is a testament to its innovative capabilities, professional expertise, and competitive edge within the pharmaceutical research and development and manufacturing service sectors.

Building upon this recognition, Laviana Pharma will further enhance its investment in technology R&D and innovation. The company aims to become a leading enterprise in the CDMO industry, offering comprehensive one-stop services to both domestic and international innovative pharmaceutical companies. This will contribute to the acceleration of global pharmaceutical innovation.

Moreover, Laviana Pharma will refine its internal management processes, augment its market competitiveness, and offer customers more efficient and superior services. These efforts will contribute to the innovation and advancement of the pharmaceutical industry.